IMM 0.00% 34.0¢ immutep limited

mentor listing, page-2

  1. 664 Posts.
    That's a company that seems similar to Springtree in function.

    Here is the company's website they refer to, and it shows that PRR is not the only company working on dendritic cell based immunotherapy:

    http://www.quantumimmunologics.com/

    You can rest assured that there is an explosion of research in this area of cancer immunotherapy now that the FDA has given the first approval for such therapy (DNDN).

    Prima is well down the research pathway, but remember that such research takes a long time and any problems along the way can stall progress significantly.

    Here's hoping though..............
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
0.000(0.00%)
Mkt cap ! $501.1M
Open High Low Value Volume
34.5¢ 35.0¢ 33.5¢ $724.1K 2.106M

Buyers (Bids)

No. Vol. Price($)
3 60483 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 55452 4
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.